Heart surgeons see innovations with tiny new pumps

Ben Sun, Star Tribune photo

[Star Tribune, November 10, 2013] A new generation of cardiac devices scheduled for human trials in Europe and the United States next year has heart surgeons talking about a possible sea change in the treatment of patients suffering from the most severe level of heart failure, which affects 150,000 to 200,000 Americans a year and kills thousands.

Dr. Ben Sun is a cardiac and thoracic surgeon for the Minneapolis Heart Institute at Abbott Northwestern Hospital and a research physician for the Minneapolis Heart Institute Foundation with a background in molecular biophysics and biochemistry. He describes himself as an “old man” in the realm of heart pumps.

Read the entire story here.

Share this article